Seroprevalence of tetanus antibody in Turkish population and effectiveness of single-dose tetanus toxoid
- PMID: 12884073
- DOI: 10.1007/s10096-003-0954-y
Seroprevalence of tetanus antibody in Turkish population and effectiveness of single-dose tetanus toxoid
Abstract
The study presented here was performed to determine the rates of immunity to tetanus in a cross section of the Turkish population and to assess the impact of a single-dose tetanus toxoid in previously unvaccinated individuals. Among 18-year-old participants who received their last tetanus booster 4 years prior to the study and 22-year-old participants who received the booster 8 years previously, certain durable protective antibody (>1 IU/ml) was detected in 100%. However, only 3.3% of 20-year-old participants who did not know whether they had been vaccinated as children or young adults had a protective antibody level. After administering a single dose of tetanus vaccine to this group, the rate of protective antibody increased from 3.3% to 96.7%. For the prevention of tetanus, the optimal policy should focus on improving rates of complete primary immunization in adults and children and giving a single booster every 10 years, or at least at age 40 or 50 years.
Similar articles
-
Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.J Infect Chemother. 2014 Jan;20(1):35-7. doi: 10.1016/j.jiac.2013.11.003. Epub 2013 Dec 11. J Infect Chemother. 2014. PMID: 24462422
-
Tetanus immunization status among women of childbearing age in Turkey.Jpn J Infect Dis. 2007 May;60(2-3):92-6. Jpn J Infect Dis. 2007. PMID: 17515639
-
Tetanus antitoxin levels among adults over 40 years of age in Central Anatolia, Turkey.Clin Microbiol Infect. 2003 Jan;9(1):33-8. doi: 10.1046/j.1469-0691.2003.00469.x. Clin Microbiol Infect. 2003. PMID: 12691540
-
[Tetanus prophylaxis after an injury; check the need for vaccination and immunoglobulin].Ned Tijdschr Geneeskd. 2013;157(38):A5906. Ned Tijdschr Geneeskd. 2013. PMID: 24330787 Review. Dutch.
-
Tetanus prophylaxis in horses: guidelines for New Zealand and Australia based on a critical appraisal of the evidence.N Z Vet J. 2024 Sep;72(5):241-255. doi: 10.1080/00480169.2024.2365283. Epub 2024 Jun 23. N Z Vet J. 2024. PMID: 38910032 Review.
Cited by
-
Gingival crevicular fluid MMP-8-concentrations in patients after acute myocardial infarction.Head Face Med. 2011 Jan 10;7:1. doi: 10.1186/1746-160X-7-1. Head Face Med. 2011. PMID: 21219642 Free PMC article.
-
Determination of the presence of diphtheria toxin in the myocardial tissue of rabbits and a female subject by using an immunofluorescent antibody method.J Clin Med Res. 2015 Jun;7(6):472-8. doi: 10.14740/jocmr2142w. Epub 2015 Apr 8. J Clin Med Res. 2015. PMID: 25883712 Free PMC article.
-
The seroepidemiology of tetanus in Catalonia, Spain.Med Microbiol Immunol. 2007 Jun;196(2):115-9. doi: 10.1007/s00430-007-0035-4. Epub 2007 Jan 23. Med Microbiol Immunol. 2007. PMID: 17242951
-
Untangling Tetanus: A Comprehensive Case Report Describing Its Diagnosis and Treatment.Cureus. 2023 Sep 5;15(9):e44702. doi: 10.7759/cureus.44702. eCollection 2023 Sep. Cureus. 2023. PMID: 37809177 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical